These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 35392074)
1. Efficacy and Safety of BCG Revaccination With Dos Anjos LRB; da Costa AC; Cardoso ADRO; Guimarães RA; Rodrigues RL; Ribeiro KM; Borges KCM; Carvalho ACO; Dias CIS; Rezende AO; Souza CC; Ferreira RRM; Saraiva G; Barbosa LCS; Vieira TDS; Conte MB; Rabahi MF; Kipnis A; Junqueira-Kipnis AP Front Immunol; 2022; 13():841868. PubMed ID: 35392074 [TBL] [Abstract][Full Text] [Related]
2. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial. Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170 [TBL] [Abstract][Full Text] [Related]
3. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark. Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115 [TBL] [Abstract][Full Text] [Related]
4. Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials. Ten Doesschate T; Moorlag SJCFM; van der Vaart TW; Taks E; Debisarun P; Ten Oever J; Bleeker-Rovers CP; Verhagen PB; Lalmohamed A; Ter Heine R; van Crevel R; van de Wijgert J; Janssen AB; Bonten MJ; van Werkhoven CH; Netea MG; Trials; 2020 Jun; 21(1):481. PubMed ID: 32503602 [TBL] [Abstract][Full Text] [Related]
5. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial. Ten Doesschate T; van der Vaart TW; Debisarun PA; Taks E; Moorlag SJCFM; Paternotte N; Boersma WG; Kuiper VP; Roukens AHE; Rijnders BJA; Voss A; Veerman KM; Kerckhoffs APM; Oever JT; van Crevel R; van Nieuwkoop C; Lalmohamed A; van de Wijgert JHHM; Netea MG; Bonten MJM; van Werkhoven CH Clin Microbiol Infect; 2022 Sep; 28(9):1278-1285. PubMed ID: 35489606 [TBL] [Abstract][Full Text] [Related]
6. Using BCG Vaccine to Enhance Nonspecific Protection of Health Care Workers During the COVID-19 Pandemic: A Randomized Controlled Trial. Madsen AMR; Schaltz-Buchholzer F; Nielsen S; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Azizi M; Hameed ZN; Johansen IS; Kofoed PE; Krause TG; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Oedegaard ES; Ostenfeld A; Soerensen MK; Wejse C; Netea MG; Aaby P; Benn CS J Infect Dis; 2024 Feb; 229(2):384-393. PubMed ID: 37774494 [TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. Suliman S; Geldenhuys H; Johnson JL; Hughes JE; Smit E; Murphy M; Toefy A; Lerumo L; Hopley C; Pienaar B; Chheng P; Nemes E; Hoft DF; Hanekom WA; Boom WH; Hatherill M; Scriba TJ J Immunol; 2016 Aug; 197(4):1100-1110. PubMed ID: 27412415 [TBL] [Abstract][Full Text] [Related]
8. Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis. Mahasha PW; Ndwandwe DE; Mavundza EJ; Shey M; Wiysonge CS BMJ Open; 2019 Oct; 9(10):e027033. PubMed ID: 31619416 [TBL] [Abstract][Full Text] [Related]
9. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil. Santos AP; Werneck GL; Dalvi APR; Dos Santos CC; Tierno PFGMM; Condelo HS; Macedo B; de Medeiros Leung JA; de Souza Nogueira J; Malvão L; Galliez R; Aguiar R; Stefan R; Knackfuss SM; da Silva EC; Castineiras TMPP; de Andrade Medronho R; E Silva JRL; Alves RLR; de Moraes Sobrino Porto LC; Rodrigues LS; Kritski AL; de Queiroz Mello FC Int J Infect Dis; 2023 May; 130():8-16. PubMed ID: 36841502 [TBL] [Abstract][Full Text] [Related]
10. Neonatal revaccination with Bacillus Calmette-Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice. Li W; Huang H; Hua W; Ben S; Liu H; Xu B; Xian Q; Tang Z; Shen H Vaccine; 2012 May; 30(21):3223-30. PubMed ID: 22342709 [TBL] [Abstract][Full Text] [Related]
11. The safety of BCG revaccination: A systematic review. Bannister S; Sudbury E; Villanueva P; Perrett K; Curtis N Vaccine; 2021 May; 39(20):2736-2745. PubMed ID: 33810902 [TBL] [Abstract][Full Text] [Related]
12. Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence. Tala-Heikkilä MM; Tuominen JE; Tala EO Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1324-7. PubMed ID: 9563757 [TBL] [Abstract][Full Text] [Related]
13. The safety of BCG revaccination in the context of COVID-19. Sánchez-García A; Támez-Guerra R; González-Saldivar G; Rodríguez-Gutiérrez R; Ramírez-García LA; Barrera FJ; González-González JG Hum Vaccin Immunother; 2023 Dec; 19(3):2271760. PubMed ID: 37936434 [TBL] [Abstract][Full Text] [Related]
14. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/ Torun S; Ozkaya S; Şen N; Kanat F; Karaman I; Yosunkaya S; Sengoren Dikis O; Asan A; Aydogan Eroglu S; Semih Atal S; Ayten O; Aksel N; Ermiş H; Özçelik N; Demirelli M; Kara I; Sümer S; Marakoğlu K; Üzer F; Uyar Y; Çiçek T; E Ünsal Z; Vatansev H; Botan Yildirim B; Kuruoğlu T; Atilla A; Ersoy Y; Kandemir B; Durduran Y; Goksin Cihan F; Demirbaş N; Yıldırım F; Tatar D; Akcay MS Pathog Glob Health; 2021 Sep; 115(6):405-411. PubMed ID: 34014806 [TBL] [Abstract][Full Text] [Related]
15. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered. Dye C J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584 [TBL] [Abstract][Full Text] [Related]
16. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2. Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial. Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739 [TBL] [Abstract][Full Text] [Related]
18. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19. Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464 [TBL] [Abstract][Full Text] [Related]
19. Revaccination with Bacillus Calmette-Guerin (BCG) vaccine does not reduce morbidity from malaria in African children. Rodrigues A; Schellenberg JA; Roth A; Benn CS; Aaby P; Greenwood B Trop Med Int Health; 2007 Feb; 12(2):224-9. PubMed ID: 17300629 [TBL] [Abstract][Full Text] [Related]
20. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic? Sharma AR; Batra G; Kumar M; Mishra A; Singla R; Singh A; Singh RS; Medhi B Allergol Immunopathol (Madr); 2020; 48(5):507-517. PubMed ID: 32653224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]